BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28191936)

  • 1. Development of Fluorophore-Labeled Thailanstatin Antibody-Drug Conjugates for Cellular Trafficking Studies.
    Kulkarni C; Finley JE; Bessire AJ; Zhong X; Musto S; Graziani EI
    Bioconjug Chem; 2017 Apr; 28(4):1041-1047. PubMed ID: 28191936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimal "Click" formulation strategy for antibody-drug conjugate synthesis.
    Vatansever EC; Kang J; Tuley A; Ward ES; Liu WR
    Bioorg Med Chem; 2020 Dec; 28(24):115808. PubMed ID: 33071032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Product Splicing Inhibitors: A New Class of Antibody-Drug Conjugate (ADC) Payloads.
    Puthenveetil S; Loganzo F; He H; Dirico K; Green M; Teske J; Musto S; Clark T; Rago B; Koehn F; Veneziale R; Falahaptisheh H; Han X; Barletta F; Lucas J; Subramanyam C; O'Donnell CJ; Tumey LN; Sapra P; Gerber HP; Ma D; Graziani EI
    Bioconjug Chem; 2016 Aug; 27(8):1880-8. PubMed ID: 27412791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate.
    Puthenveetil S; He H; Loganzo F; Musto S; Teske J; Green M; Tan X; Hosselet C; Lucas J; Tumey LN; Sapra P; Subramanyam C; O'Donnell CJ; Graziani EI
    PLoS One; 2017; 12(5):e0178452. PubMed ID: 28558059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
    VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M
    Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
    Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
    PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
    Harper J; Mao S; Strout P; Kamal A
    Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET.
    Adumeau P; Vivier D; Sharma SK; Wang J; Zhang T; Chen A; Agnew BJ; Zeglis BM
    Mol Pharm; 2018 Mar; 15(3):892-898. PubMed ID: 29356543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
    Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
    Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.
    Frigerio M; Kyle AF
    Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates.
    DeVay RM; Delaria K; Zhu G; Holz C; Foletti D; Sutton J; Bolton G; Dushin R; Bee C; Pons J; Rajpal A; Liang H; Shelton D; Liu SH; Strop P
    Bioconjug Chem; 2017 Apr; 28(4):1102-1114. PubMed ID: 28151644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug Conjugates.
    Lee BC; Chalouni C; Doll S; Nalle SC; Darwish M; Tsai SP; Kozak KR; Del-Rosario G; Yu SF; Erickson H; Vandlen R
    Bioconjug Chem; 2018 Jul; 29(7):2468-2477. PubMed ID: 29856915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates.
    Mahalingaiah PK; Ciurlionis R; Durbin KR; Yeager RL; Philip BK; Bawa B; Mantena SR; Enright BP; Liguori MJ; Van Vleet TR
    Pharmacol Ther; 2019 Aug; 200():110-125. PubMed ID: 31028836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
    Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
    Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggered Drug Release from an Antibody-Drug Conjugate Using Fast "Click-to-Release" Chemistry in Mice.
    Rossin R; van Duijnhoven SM; Ten Hoeve W; Janssen HM; Kleijn LH; Hoeben FJ; Versteegen RM; Robillard MS
    Bioconjug Chem; 2016 Jul; 27(7):1697-706. PubMed ID: 27306828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogeneous Antibody-Drug Conjugates via Glycoengineering.
    Tang F; Shi W; Huang W
    Methods Mol Biol; 2019; 2033():221-238. PubMed ID: 31332757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody-Drug Conjugates.
    van Geel R; Wijdeven MA; Heesbeen R; Verkade JM; Wasiel AA; van Berkel SS; van Delft FL
    Bioconjug Chem; 2015 Nov; 26(11):2233-42. PubMed ID: 26061183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
    Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
    MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification.
    Su D; Kozak KR; Sadowsky J; Yu SF; Fourie-O'Donohue A; Nelson C; Vandlen R; Ohri R; Liu L; Ng C; He J; Davis H; Lau J; Del Rosario G; Cosino E; Cruz-Chuh JD; Ma Y; Zhang D; Darwish M; Cai W; Chen C; Zhou H; Lu J; Liu Y; Kaur S; Xu K; Pillow TH
    Bioconjug Chem; 2018 Apr; 29(4):1155-1167. PubMed ID: 29481745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
    Singh SK; Luisi DL; Pak RH
    Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.